Review article · 2014
Conference abstractPublished 12 Aug 2013
Toward safe and effective gene and cell therapies using human artificial chromosomes and stem cells
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Random integration of conventional gene delivery vectors can be associated with transgene-silencing. Furthermore, integrated sequences can activate oncogenes adjacent to the insertion site, resulting in the activation or silencing of transgenes. Human artificial chromosome (HAC) is exogenous mini-chromosome artificially created by chromosome engineering. Various HACs exhibit several potential characteristics desired for an ideal gene delivery vector, including stable episomal maintenance and the capacity to carry large genomic loci with their regulatory elements, thus allowing the physiological regulation of the introduced gene in a manner similar to that of native chromosomes. For ideal gene and cell - therapy using iPS cells, following are crucial: efficient generation and differentiation of iPS cells; no integration of transgene into the host genome. Most importantly, it is necessary to evade a problem of teratoma formation and malignant transformation when using the iPS cells to cell transplantation therapy. Currently, we have constructed HAC-based cell-reprogramming vectors. Then, mouse and human iPS cells were generated using the HAC vectors. These iPS cells have no integration of transgene, and showed normal karyotype. To show their pluripotency, these iPS cells differentiated to three germ layer cells by generation of teratoma. We also aim to develop a safeguard system to eliminate undifferentiated cells and malignant transformation of transplanted cells using HAC.
Ask about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Short communication · 2012
Towards a Combined Gene and Cell Therapy for Lung Diseases: The Case of Induced Pluripotent Stem Cells
Research article · 2015
Successful Induction of Pluripotent Stem Cells From a Fabry Disease Mouse Model: Toward the Development of Safe Lentiviral Gene Therapy
Conference abstract · 12 Aug 2013
New vectors for gene delivery: Human and mouse artificial chromosomes
Conference abstract · 12 Sep 2016
Towards the generation of fully functional human pluripotent stem cell derived hepatocytes
More from this journal
The newest in Advancements in Genetic Engineering.
Commentary · 1 Jul 2026
Genetic Engineering in Enhancing Human Muscle Regeneration for Degenerative Muscle Disorders
Commentary · 1 Jul 2026
Genetic Engineering in Engineering Human Liver Detoxification Pathways for Chronic Toxic Load Disorders
Perspective · 1 Jul 2026
Genetic Engineering in Developing Synthetic Neural Circuits for Cognitive Function Restoration
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAdvancements in Genetic Engineering
- SubjectGenetics & Molecular Biology
- SubjectEngineering
- BylineArticles whose byline prints “Narumi Uno”
- BylineArticles whose byline prints “Kana Ueda”
- BylineArticles whose byline prints “Yuichi Iida”
- BylineArticles whose byline prints “Yuna Yakura”
- BylineArticles whose byline prints “Hajime Kurosaki”
- BylineArticles whose byline prints “Katsuhiro Uno”
- BylineArticles whose byline prints “Mitsuhiko Osaki”
- BylineArticles whose byline prints “Tetsuya Ohbayashi”

